Cardiac Sarcoidosis and Giant Cell Myocarditis: Actually, 2 Ends of the Same Disease?
| Autor: | Vidhya Nair, David H. Birnie, John P. Veinot |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
Adult
Male Pathology medicine.medical_specialty Sarcoidosis Cardiomyopathy Cardiac sarcoidosis Disease Giant cell myocarditis Giant Cells cardiac sarcoidosis Cause of Death Natriuretic Peptide Brain Humans Medicine Original Research Aged Retrospective Studies Heart Failure business.industry Incidence Myocardium Editorials inflammatory heart disease Middle Aged United States Survival Rate Myocarditis Editorial Population Surveillance Female Cardiomyopathies Cardiology and Cardiovascular Medicine business giant cell myocarditis Biomarkers Follow-Up Studies Forecasting |
| Zdroj: | Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease |
| ISSN: | 2047-9980 |
| DOI: | 10.1161/jaha.121.020542 |
| Popis: | Background Cardiac sarcoidosis (CS) and giant cell myocarditis (GCM) share many histopathologic and clinical features. Whether they are parts of a one‐disease continuum has been discussed. Methods and Results We compared medical record data of 351 CS and 28 GCM cases diagnosed in Finland since the late 1980s and followed until February 2018 for a composite end point of cardiac death, aborted sudden death, and heart transplantation. Heart failure was the presenting manifestation in 50% versus 15% (P |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Plný text